28. Note to the cash flow statement
|
31 December |
|
|---|---|---|
(thousands of €) |
2022 |
2021 |
Adjustment for non-cash transactions |
|
|
Depreciation and impairment |
65,566 |
34,636 |
Share-based compensation expenses |
88,506 |
70,726 |
Increase/decrease (-) in retirement benefit obligations and provisions |
136 |
(2,347) |
Unrealized exchange gains and non-cash other financial result |
(41,970) |
(57,073) |
Discounting effect of non-current deferred income |
7,672 |
9,289 |
Discounting effect of other non-current liabilities |
2,271 |
- |
Fair value re-measurement of warrants |
(186) |
(2,960) |
Net change in (fair) value of current financial investments |
(6,929) |
(119) |
Fair value adjustment financial assets held at fair value through profit or loss |
- |
4,919 |
Other non-cash expenses |
2,229 |
648 |
Total adjustment for non-cash transactions |
117,296 |
57,718 |
|
|
|
Adjustment for items to disclose separately under operating |
|
|
Interest expense |
6,967 |
11,656 |
Interest income |
(14,344) |
(2,853) |
Tax expense |
2,844 |
2,423 |
Total adjustment for items to disclose separately under operating |
(4,533) |
11,227 |
|
|
|
Adjustment for items to disclose under investing and financing |
|
|
Gain on sale of subsidiaries |
- |
(22,191) |
Gain on sale of fixed assets |
(23) |
- |
Realized exchange gain on sale of current financial investments |
- |
(6,645) |
Interest income on current financial assets |
(3,766) |
(12) |
Total adjustment for items to disclose separately under investing and financing |
(3,789) |
(28,847) |
|
|
|
Change in working capital other than deferred income |
|
|
Increase in inventories |
(34,588) |
(21,168) |
Decrease in receivables |
68,984 |
79,859 |
Decrease in liabilities |
(2,083) |
(35,353) |
Total change in working capital other than deferred income |
32,313 |
23,337 |
As the increase in trade and other liabilities and other non-current liabilities in the balance sheet was mainly related to the acquisition of Cellpoint, we show a decrease in liabilities in the annex to the cash flow statement.